bioventus
-
Biologics
Bioventus Expands to Mexico with DUROLANE® for Knee Osteoarthritis Patients
November 14, 2016 HOOFDDORP, The Netherlands–(BUSINESS WIRE)–Bioventus, a leader in orthobiologic solutions, has entered the patient care market in Mexico.…
Read More » -
Biologics
Bioventus Appoints Andrew McCartney Managing Director, International for EMEA
November 7, 2016 DURHAM, N.C.–(BUSINESS WIRE)– Bioventus, a global leader in orthobiologic solutions, today announced the appointment of Andrew McCartney…
Read More » -
Biologics
Bioventus Launches EXOGEN® Ultrasound Bone Healing System in the Kingdom of Saudi Arabia
September 19, 2016 HOOFDDORP, The Netherlands–(BUSINESS WIRE)–Bioventus, a leader in orthobiologic solutions, today announced the launch of itsEXOGEN Ultrasound Bone…
Read More » -
Biologics
Bioventus Launches GELSYN-3™ for Treatment of Knee Osteoarthritis Pain
DURHAM, N.C.–(BUSINESS WIRE)– August 9, 2016 Bioventus, a global leader in orthobiologic solutions, today announced it has launched GELSYN-3™, a…
Read More » -
Financial
BioVentus delays $150m IPO
JULY 29, 2016 BY FINK DENSFORD Orthobiologics maker Bioventus postponed its initial public offering which was slated to raise up to…
Read More » -
Financial
Bioventus sets terms on $150m IPO
JULY 19, 2016 BY FINK DENSFORD Orthobiologics maker Bioventus today released terms for its $150 million initial public offering, looking to…
Read More » -
Financial
Bone-Healing Therapies Firm Bioventus Files for IPO
By Frank Vinluan – June 30, 2016 Xconomy Raleigh-Durham — Bioventus, a company that develops treatments that harness the body’s…
Read More » -
Biologics
Bioventus Extends Distribution Agreement for SUPARTZ FX™
July 01, 2016 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, today announced it has entered into an…
Read More » -
Biologics
Durham’s Bioventus acquires knee pain product from Swiss company
Jason deBruyn Fresh off an acquisition that expanded its portfolio more broadly in the surgery market, Durham-based Bioventus reached a deal with…
Read More » -
Biologics
Bioventus Launches DUROLANE® for Osteoarthritis Patients in Taiwan
HOOFDDORP, The Netherlands–(BUSINESS WIRE)–Bioventus, a leader in orthobiologic solutions, today announced its entry into the patient care market in Taiwan…
Read More » -
Spine
5 recent orthopedic, spine device company mergers & acquisitions
By Mary Rechtoris Here are five recent mergers and acquisitions that took place among spine and orthopedic companies. Cytos Biotechnology and Kuros…
Read More » -
Biologics
Bioventus Acquires BioStructures, Expands Surgical Orthobiologics Offering
DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, today announced it has acquired BioStructures LLC, a proprietary developer and marketer of…
Read More » -
Biologics
Bioventus Launches SUPARTX FX™ Now with Expanded Safety Label for Repeat Injection Cycles in Knee Osteoarthritis
Bioventus Launches SUPARTZ FX™Now with Expanded Safety Label for Repeat Injection Cycles in Knee Osteoarthritis DURHAM, NC – October 12,…
Read More » -
Biologics
Bioventus Leaders Promoted to Manage International Business and Expansion
DURHAM, N.C.–(BUSINESS WIRE)–Bioventus®, a leader in orthobiologic solutions, today announced promotions to its executive leadership team. Effective immediately Andrew Hosmer…
Read More » -
Recon
LDR, MEDTECH, Paradigm Spine & more — 14 key notes
By Anuja Vaidya Here are 14 key notes on spine and orthopedic device companies this week. Bioventus named a new vice…
Read More »